Wanping Geng

532 total citations
18 papers, 252 citations indexed

About

Wanping Geng is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Wanping Geng has authored 18 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Wanping Geng's work include Anesthesia and Pain Management (3 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Anesthesia and Sedative Agents (3 papers). Wanping Geng is often cited by papers focused on Anesthesia and Pain Management (3 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Anesthesia and Sedative Agents (3 papers). Wanping Geng collaborates with scholars based in United States, Switzerland and Germany. Wanping Geng's co-authors include Heidi Foth, Andreas Schwab, K. Sandy Pang, Georg F. Kahl, Michael E. Dunn, Thomas P. Singer, Igor Mikaelian, Lucette Doessegger, Igor A. Sherman and Ford Barker and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Toxicological Sciences.

In The Last Decade

Wanping Geng

17 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wanping Geng United States	10	74	64	62	44	38	18	252
Hironori Sakai Japan	13	38 0.5×	109 1.7×	96 1.5×	18 0.4×	103 2.7×	29	402
Tai‐Ming Ko Taiwan	9	23 0.3×	60 0.9×	67 1.1×	26 0.6×	32 0.8×	22	406
Russell Wada United States	8	70 0.9×	136 2.1×	44 0.7×	19 0.4×	19 0.5×	16	391
Lei Yao China	11	57 0.8×	104 1.6×	26 0.4×	27 0.6×	23 0.6×	19	300
Danielle Armas United States	9	52 0.7×	74 1.2×	49 0.8×	65 1.5×	34 0.9×	18	312
K Brune United States	8	140 1.9×	79 1.2×	67 1.1×	10 0.2×	33 0.9×	19	314
Kazuhisa Arakawa Japan	9	109 1.5×	119 1.9×	75 1.2×	6 0.1×	77 2.0×	29	314
Hüseyin Melek Türkiye	10	32 0.4×	59 0.9×	82 1.3×	14 0.3×	8 0.2×	34	351
Joseph Ipe United States	9	20 0.3×	123 1.9×	67 1.1×	26 0.6×	22 0.6×	18	270
Kristin Karlsson Sweden	9	15 0.2×	55 0.9×	27 0.4×	37 0.8×	17 0.4×	13	287

Countries citing papers authored by Wanping Geng

Since Specialization

Citations

This map shows the geographic impact of Wanping Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanping Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanping Geng more than expected).

Fields of papers citing papers by Wanping Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanping Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanping Geng. The network helps show where Wanping Geng may publish in the future.

Co-authorship network of co-authors of Wanping Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Wanping Geng. A scholar is included among the top collaborators of Wanping Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanping Geng. Wanping Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Hu, Hong‐Ming, Rongliang Lou, Wanping Geng, et al.. (2022). 1171 CAN1012: a selective and potent TLR7 agonist with strong antitumoral properties mediated by localized innate immune activation. Regular and Young Investigator Award Abstracts. A1214–A1214. 2 indexed citations

Burvenich, Ingrid J.G., Hui Gan, Angela Rigopoulos, et al.. (2021). Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. European Journal of Nuclear Medicine and Molecular Imaging. 48(10). 3075–3088. 20 indexed citations

Keller, Stephen, Jorge Quiroz, Enaksha Wickremsinhe, et al.. (2021). The Effectiveness of Quality Control Samples in Pharmaceutical Bioanalysis. Bioanalysis. 13(3). 135–145.

Vugmeyster, Yulia, Justin Wilkins, Wanping Geng, et al.. (2018). Selection of the recommended phase 2 dose (RP2D) for M7824 (MSB0011359C), a bifunctional fusion protein targeting TGF-β and PD-L1.. Journal of Clinical Oncology. 36(15_suppl). 2566–2566. 8 indexed citations

Goldinger, Simone M., Jeannine D. Rinderknecht, Reinhard Dummer, et al.. (2015). A single‐dose mass balance and metabolite‐profiling study of vemurafenib in patients with metastatic melanoma. Pharmacology Research & Perspectives. 3(2). e00113–e00113. 22 indexed citations

Mikaelian, Igor, Michael E. Dunn, Diane R. Mould, et al.. (2013). Differential analysis of transient increases of serumcTnIin response to handling in rats. Pharmacology Research & Perspectives. 1(2). e00011–e00011. 6 indexed citations

Qian, Yimin, Wendy L. Corbett, Steven J. Berthel, et al.. (2013). Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 4(4). 414–418. 11 indexed citations

Dunn, Michael E., Tanja S. Zabka, Wanping Geng, et al.. (2012). Myocardial Mononuclear Cell Infiltrates Are Not Associated with Increased Serum Cardiac Troponin I in Cynomolgus Monkeys. Toxicologic Pathology. 40(4). 647–650. 5 indexed citations

Kolinsky, Kenneth, Christian Tovar, Yue Zhang, et al.. (2011). Preclinical evaluation of the novel multi-targeted agent R1530. Cancer Chemotherapy and Pharmacology. 68(6). 1585–1594. 10 indexed citations

10.

Dunn, Michael E., Igor Mikaelian, Steven E. Lipshultz, et al.. (2011). The Complete Pharmacokinetic Profile of Serum Cardiac Troponin I in the Rat and the Dog. Toxicological Sciences. 123(2). 368–373. 38 indexed citations

11.

Mikaelian, I., Andreas Buneß, Rafael Oliveira Fernandes, et al.. (2010). Serum cardiac troponin I concentrations transiently increase in rats given rosiglitazone. Toxicology Letters. 201(2). 110–115. 7 indexed citations

12.

Tellier, Pierre, et al.. (2010). A 4-Week Intrathecal Toxicity and Pharmacokinetic Study With Trastuzumab in Cynomolgus Monkeys. International Journal of Toxicology. 29(3). 259–267. 25 indexed citations

13.

Schwab, Andreas, Wanping Geng, & K. Sandy Pang. (1998). Application of the Dispersion Model for Description of the Outflow Dilution Profiles of Noneliminated Reference Indicators in Rat Liver Perfusion Studies. Journal of Pharmacokinetics and Biopharmaceutics. 26(2). 163–181. 16 indexed citations

14.

Geng, Wanping, Markus Ebke, & Heidi Foth. (1995). Prilocaine elimination by isolated perfused rat lung and liver. Naunyn-Schmiedeberg s Archives of Pharmacology. 351(1). 93–8. 3 indexed citations

15.

Foth, Heidi, Wanping Geng, N. Krug, & F. Vetterlein. (1995). Pulmonary uptake of bupivacaine in isolated perfused rat lung. Naunyn-Schmiedeberg s Archives of Pharmacology. 351(1). 99–106. 6 indexed citations

16.

Kietzmann, Daniela, et al.. (1995). Transpulmonary disposition of prilocaine, mepivacaine, and bupivacaine in humans in the course of epidural anaesthesia. Acta Anaesthesiologica Scandinavica. 39(7). 885–890. 13 indexed citations

17.

Pang, K. Sandy, Igor A. Sherman, Andreas Schwab, et al.. (1994). Role of the Hepatic Artery in the Metabolism of Phenacetin and Acetaminophen: An Intravital Microscopic and Multiple–Indicator Dilution Study in Perfused Rat Liver. Hepatology. 20(3). 672–683. 31 indexed citations

18.

Geng, Wanping, et al.. (1990). Sensitive determination of bupivacaine in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 527(1). 201–207. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact